Potentiation of alpha-adrenoceptor-mediated responses following chronic beta-adrenoceptor stimulation in the rat heart.
1. Noradrenaline and isoprenaline were infused subcutaneously in rats by use of Alzet osmotic minipumps. The effects of catecholamine infusion on ventricular alpha- and beta-adrenoceptor density and also the responses of isolated cardiac tissues were compared with saline infusion. 2. Noradrenaline (1 mg kg-1) or isoprenaline (40 micrograms kg-1) infused for 3 days resulted in a desensitization of beta-adrenoceptor-mediated responses of isolated left atria and papillary muscles. Concentration-response curves to isoprenaline were shifted to the right in left atria whilst maximum responses were reduced in papillary muscles. Right atrial rate responses were not affected by infusions of catecholamines. 3. Infusions of either noradrenaline or isoprenaline resulted in a supersensitivity of alpha-adrenoceptor-mediated responses in isolated papillary muscles with leftward displacements of concentration-response curves to phenylephrine. 4. The density of both ventricular [3H]-dihydroalprenolol and [3H]-prazosin binding sites was reduced following noradrenaline infusion. Isoprenaline infusion reduced only the density of [3H]-dihydroalprenolol binding sites. 5. Noradrenaline infusion therefore 'down-regulates' both alpha- and beta-adrenoceptors in the rat heart but at the same time ventricular alpha-adrenoceptor-mediated responses are enhanced. Isoprenaline similarly enhances responses to phenylephrine and possible mechanisms for this phenomenon are discussed.
Butterfield
M C
MC
Department of Biomedical Science, University of Sheffield, Western Bank.
Chess-Williams
R
R
D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000818:Animals; D002304:Cardiac Pacing, Artificial; D004082:Dihydroalprenolol / Q000494:pharmacology; D004343:Drug Implants; D004357:Drug Synergism; D006321:Heart / Q000187:drug effects*; D006325:Heart Atria / Q000187:drug effects; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D007700:Kinetics; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D010210:Papillary Muscles / Q000187:drug effects; D010656:Phenylephrine / Q000494:pharmacology; D011869:Radioligand Assay; D051381:Rats; D017208:Rats, Wistar; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects / Q000502:physiology*
D000318:Adrenergic beta-Agonists; D004343:Drug Implants; D011942:Receptors, Adrenergic, alpha; D010656:Phenylephrine; D004082:Dihydroalprenolol; D007545:Isoproterenol; D009638:Norepinephrine